These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16682435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
    Swanberg SE, Nagarajan RP, Peddada S, Yasui DH, LaSalle JM.
    Hum Mol Genet; 2009 Feb 01; 18(3):525-34. PubMed ID: 19000991
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L, Chen K, Lavery LA, Baker SA, Shaw CA, Li W, Zoghbi HY.
    Proc Natl Acad Sci U S A; 2015 Apr 28; 112(17):5509-14. PubMed ID: 25870282
    [Abstract] [Full Text] [Related]

  • 6. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
    Miyake K, Hirasawa T, Soutome M, Itoh M, Goto Y, Endoh K, Takahashi K, Kudo S, Nakagawa T, Yokoi S, Taira T, Inazawa J, Kubota T.
    BMC Neurosci; 2011 Aug 08; 12():81. PubMed ID: 21824415
    [Abstract] [Full Text] [Related]

  • 7. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez AF, Esteller M.
    PLoS One; 2008 Aug 08; 3(11):e3669. PubMed ID: 18989361
    [Abstract] [Full Text] [Related]

  • 8. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR.
    Hum Mol Genet; 2007 Mar 15; 16(6):640-50. PubMed ID: 17309881
    [Abstract] [Full Text] [Related]

  • 9. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
    Jordan C, Li HH, Kwan HC, Francke U.
    BMC Med Genet; 2007 Jun 20; 8():36. PubMed ID: 17584923
    [Abstract] [Full Text] [Related]

  • 10. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W, Pan H.
    Yi Chuan; 2014 Jul 20; 36(7):625-30. PubMed ID: 25076025
    [Abstract] [Full Text] [Related]

  • 11. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM, Goldstine J, Balmer D, Greco CM.
    Hum Mol Genet; 2001 Aug 15; 10(17):1729-40. PubMed ID: 11532982
    [Abstract] [Full Text] [Related]

  • 12. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
    Nectoux J, Fichou Y, Rosas-Vargas H, Cagnard N, Bahi-Buisson N, Nusbaum P, Letourneur F, Chelly J, Bienvenu T.
    J Cell Mol Med; 2010 Jul 15; 14(7):1962-74. PubMed ID: 20569274
    [Abstract] [Full Text] [Related]

  • 13. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE, Johnston MV, Blue ME.
    Brain Dev; 2005 Nov 15; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [Abstract] [Full Text] [Related]

  • 14. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
    Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R, Kilstrup-Nielsen C, Landsberger N.
    Hum Mol Genet; 2010 Aug 15; 19(16):3114-23. PubMed ID: 20504995
    [Abstract] [Full Text] [Related]

  • 15. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.
    Thatcher KN, LaSalle JM.
    Epigenetics; 2006 Aug 15; 1(1):24-31. PubMed ID: 17464364
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ, Akbarian S, Tudor M, Jaenisch R.
    Nat Genet; 2001 Mar 15; 27(3):327-31. PubMed ID: 11242118
    [Abstract] [Full Text] [Related]

  • 17. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
    Cheung AY, Horvath LM, Grafodatskaya D, Pasceri P, Weksberg R, Hotta A, Carrel L, Ellis J.
    Hum Mol Genet; 2011 Jun 01; 20(11):2103-15. PubMed ID: 21372149
    [Abstract] [Full Text] [Related]

  • 18. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y, Minami Y, Umemura Y, Watanabe H, Ono D, Nakamura W, Takahashi T, Honma S, Kondoh G, Matsuishi T, Yagita K.
    Genes Cells; 2015 Dec 01; 20(12):992-1005. PubMed ID: 26456390
    [Abstract] [Full Text] [Related]

  • 19. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P, Chinaranagari S, Chaudhary J.
    Biochimie; 2015 May 01; 112():139-50. PubMed ID: 25778840
    [Abstract] [Full Text] [Related]

  • 20. The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)-Implications for Parkinson's Disease and Rett Syndrome.
    Schmitt I, Evert BO, Sharma A, Khazneh H, Murgatroyd C, Wüllner U.
    Mol Neurobiol; 2024 Oct 01; 61(10):7830-7844. PubMed ID: 38429622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.